Mimedx Group Return on Equity

Mimedx Group (MDXG) currently reports a ROE of -8.89%. That is below the Industrials sector average of 36.13%. Use the charts on this page to explore Mimedx Group's ROE history and peer comparisons.

Mimedx Group's ROE of -8.89% is lower than the Industrials sector average of 36.13%. That is roughly 124.6% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Mimedx Group's current -8.89% should be judged against Industrials norms (sector average: 36.13%) and against MDXG's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -8.89%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Industrials average is 36.13%. From there, open related valuation or income-statement pages for Mimedx Group, and consider following MDXG for alerts when major investors trade the stock.

Mimedx Group is classified in the Industrials sector. On ROE, it currently shows -8.89% versus a sector average near 36.13%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Industrials are usually more informative than comparing MDXG with unrelated industries.